NBEO Part 1 Pharmacology and Systemic Health Review

Pharmacology is 11-17% of scored items on NBEO Part 1, and systemic health is the largest single condition area at 55-75 items. Pharmacology is tested in disease context, not as isolated drug facts. The in-exam searchable generic-brand list means you should focus on mechanisms, indications, side effects, and contraindications rather than brand names. Systemic health items connect anatomy, pharmacology, immunology, and pathology into clinical scenarios. We'll walk you through how to study them together instead of trying to memorize endless drug lists.

The current NBEO Part 1 blueprint is organized around clinical conditions, and systemic health is the biggest condition block. This means a large portion of the exam asks you to manage patients with systemic diseases that have ocular manifestations. Pharmacology is the therapeutic lens through which many of those conditions are tested. Studying these two areas together is far more efficient than studying them separately.

Systemic Health: The Largest Condition Area

Systemic health accounts for 55-75 items on the condition-based outline. It is also one of the most variable areas from form to form. Some administrations are heavy on specific systemic disorders, while others lean toward uveitis or anterior segment disease. The safest approach is broad coverage of the most common systemic conditions with ocular involvement.

High-yield systemic health topics include:

• Diabetes mellitus: diabetic retinopathy, cataract, cranial nerve palsies, and management timing.
• Hypertension: hypertensive retinopathy and choroidopathy.
• Autoimmune diseases: rheumatoid arthritis, systemic lupus erythematosus, Sjogren syndrome, and scleritis.
• Thyroid eye disease and Graves ophthalmopathy.
• Vasculitis: giant cell arteritis, polyarteritis nodosa, and Behçet disease.
• Infectious diseases: syphilis, tuberculosis, HIV, and toxoplasmosis.
• Sarcoidosis and its ocular findings.
• Nutritional and metabolic disorders affecting vision.

For each condition, know the ocular findings, the systemic associations, the appropriate workup, and the role of the optometrist in co-management.

Pharmacology in Disease Context

Pharmacology items are rarely standalone drug identification questions. They usually present a patient with a condition and ask you to choose the right medication, manage side effects, or avoid a contraindication. The exam provides a searchable generic-brand reference list, so memorizing brand names is not the priority.

Glaucoma Medications

Glaucoma medications are a pharmacology staple. You should know:

• Prostaglandin analogs: mechanism, side effects, and dosing.
• Beta-blockers: mechanism, contraindications, and systemic side effects.
• Alpha-agonists: mechanism and side effects.
• Carbonic anhydrase inhibitors: topical and oral forms, side effects.
• Miotics and rho kinase inhibitors.
• Combination products and prescribing hierarchy.

The key is to know not just which drug lowers pressure, but which is appropriate for a specific patient profile.

Anti-Infectives

Anti-infective pharmacology covers:

• Antibiotics for bacterial keratitis and blepharitis.
• Antivirals for herpes simplex and herpes zoster.
• Antifungals for fungal keratitis.
• Antiparasitics for acanthamoeba and toxoplasmosis.
• The role of steroids alongside anti-infectives.

Know the spectrum, route of administration, and major side effects for each class.

Anti-Inflammatory Agents

Anti-inflammatory pharmacology includes:

• Topical steroids: potency, indications, and risks (cataract, glaucoma, infection).
• NSAIDs: topical and systemic uses in ocular surface and postoperative care.
• Immunomodulators for severe ocular surface disease and uveitis.
• Cycloplegics and mydriatics for uveitis and refraction.

Systemic Medications with Ocular Side Effects

A common exam pattern asks about a systemic medication that causes ocular toxicity. High-yield examples include:

• Amiodarone and corneal deposits.
• Hydroxychloroquine and macular toxicity.
• Ethambutol and optic neuropathy.
• Corticosteroids and cataract or glaucoma.
• Bisphosphonates and inflammatory eye disease.
• Topiramate and angle-closure.

For each, know the ocular finding, the mechanism, and the management.

How to Study Pharmacology

Pharmacology is best learned through repetition and clinical application. Use flashcards for drug classes, mechanisms, and side effects. Study by clinical scenario rather than by drug list. For example, instead of memorizing all beta-blockers, ask which beta-blocker is appropriate for a patient with asthma and which is contraindicated.

Group drugs by class and compare them across the same dimensions: mechanism, indication, side effects, contraindications, and monitoring. This structure makes retrieval easier under pressure.

Connecting Systemic Health and Pharmacology

The most efficient study approach integrates systemic disease and pharmacology. For each systemic condition, ask:

• What are the ocular manifestations?
• What is the underlying mechanism?
• What pharmacologic agents are used, and what are their side effects?
• What monitoring does the optometrist provide?
• When is referral or co-management indicated?

This integrated approach mirrors the condition-based blueprint and prepares you for the vignette-style items that dominate the exam.

Ocular Pharmacology in Special Populations

Pharmacology items often test whether you can adjust a medication choice for a specific patient profile. Age, pregnancy status, and systemic comorbidities change the risk-benefit balance of many common ocular drugs.

In children, cycloplegic refraction requires careful agent selection. Cyclopentolate and tropicamide are commonly used, but atropine may be needed for stronger cycloplegia or amblyopia management. Children are more susceptible to systemic absorption of topical agents, so punctal occlusion and reduced dosing are important. In pregnancy, many systemic medications are avoided, and topical agents are generally preferred when ocular treatment is necessary. Beta-blockers and prostaglandin analogs have specific pregnancy and lactation considerations that may appear in management questions.

In elderly patients, polypharmacy increases the risk of drug interactions. A topical beta-blocker can precipitate bronchospasm in a patient with asthma or mask hypoglycemia in a patient with diabetes. Oral carbonic anhydrase inhibitors can worsen kidney function or cause metabolic acidosis. These contraindications are classic exam material because they test whether you know a drug well enough to avoid it in the wrong patient.

When an item presents a special population, pause and identify the contraindications and monitoring requirements before selecting the drug. This extra step is often the difference between a tempting answer and the correct one.

Renal and hepatic disease also alter drug metabolism. Oral acetazolamide is cleared by the kidneys, so dose adjustment is needed in renal impairment. Systemic corticosteroids can worsen glycemic control and bone density. When a patient has multiple comorbidities, the safest choice is often the topical agent with the fewest systemic effects, provided it still achieves the therapeutic goal.

If you want pharmacology and systemic health video crash courses, thousands of questions, and AI tools to generate targeted practice on your weak areas, check out plans and pricing when you're ready.

A Case-Based Integration Exercise

The best way to study pharmacology and systemic health is to walk through a patient case from presentation to management. Here is a template you can apply to any systemic disease with ocular involvement.

Step 1: Identify the ocular findings. What does the patient present with? Is it anterior segment inflammation, retinal changes, optic nerve involvement, or a motility problem? The location of the finding narrows the differential diagnosis.

Step 2: Connect to the systemic disease. Which systemic conditions are associated with these findings? For example, uveitis with oral ulcers may suggest Behçet disease, while uveitis with pulmonary symptoms may suggest sarcoidosis or tuberculosis.

Step 3: Choose the diagnostic workup. What tests are appropriate? This may include blood tests, imaging, infectious disease testing, or referral to rheumatology. The workup should be guided by the most likely systemic associations.

Step 4: Select the pharmacologic management. What drug class is indicated? Steroids for inflammation, anti-infectives for infection, immunomodulators for refractory autoimmune disease. Consider the side effects and contraindications for the specific patient.

Step 5: Define the optometrist's role. Is this condition managed by optometry alone, or does it require co-management? Know when to refer and when to monitor. Many exam items test the appropriate level of care.

Quick Review Checklist for Pharmacology and Systemic Health

Use this checklist to make sure your pharmacology and systemic health study is integrated and clinical.

• You can identify the major systemic diseases with ocular manifestations.
• You know the ocular findings, workup, and management for diabetes, hypertension, and autoimmune diseases.
• You understand the mechanisms and side effects of glaucoma medications.
• You know the major anti-infective, anti-inflammatory, and cycloplegic/mydrriatic drug classes.
• You can recognize systemic medications with important ocular side effects.
• You practice pharmacology in disease context rather than memorizing isolated drug facts.
• You have reviewed the generic-brand reference list concept for the exam.
• You connect each drug class to the clinical conditions where it is used.

Pharmacology is learned best through cases, not drug lists.

What This Means for You

Pharmacology and systemic health on NBEO Part 1 are inseparable. The exam will present a patient with a systemic disease and ask you to choose a drug, manage a side effect, or recognize a contraindication. Your job is to know the drug classes well enough to apply them in context. Do not memorize brand names; the exam provides a reference list. Do not memorize isolated facts; connect each drug to the diseases where it is used. Practice with case-based questions, and your pharmacology score will improve naturally. In our experience, the students who crush pharmacology are the ones who stop memorizing and start thinking like clinicians.

Key Terms to Remember

• Systemic disease: A disease affecting the body as a whole, often with ocular manifestations tested on NBEO Part 1.
• Ocular manifestation: A sign or symptom in the eye caused by a systemic or local condition, such as diabetic retinopathy or hypertensive retinopathy.
• Generic-brand reference list: The searchable list provided during the exam that links generic drug names to brand names.
• Drug class: A group of medications with similar mechanisms of action, such as prostaglandin analogs or beta-blockers.
• Contraindication: A condition or factor that makes a particular drug or treatment inadvisable.
• Ocular side effect: An adverse effect on the eye or vision from a systemic medication, such as hydroxychloroquine macular toxicity.

NBEO Part 1 pharmacology and systemic health are tested together; focus on drug classes, mechanisms, ocular side effects, and the most common systemic diseases with ocular manifestations. If you want a platform that helps you study these topics in an integrated, case-based way, we'd love to help. See plans and pricing when you're ready to prepare.